TPP1 and CLN2 disease: Recombinant tripeptidyl tripeptidase 1 (TPP1, cerliponase alfa) was approved for the treatment of Ceroid Lipofuscinosis 2 (CLN2) disease following ICV enzyme infusion in a lateral ventricle [110].